IBDEI1LL ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25532,2)
 ;;=^5002449
 ;;^UTILITY(U,$J,358.3,25533,0)
 ;;=D86.85^^107^1221^42
 ;;^UTILITY(U,$J,358.3,25533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25533,1,3,0)
 ;;=3^Sarcoid Myocarditis
 ;;^UTILITY(U,$J,358.3,25533,1,4,0)
 ;;=4^D86.85
 ;;^UTILITY(U,$J,358.3,25533,2)
 ;;=^5002450
 ;;^UTILITY(U,$J,358.3,25534,0)
 ;;=D86.83^^107^1221^40
 ;;^UTILITY(U,$J,358.3,25534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25534,1,3,0)
 ;;=3^Sarcoid Iridocyclitis
 ;;^UTILITY(U,$J,358.3,25534,1,4,0)
 ;;=4^D86.83
 ;;^UTILITY(U,$J,358.3,25534,2)
 ;;=^5002448
 ;;^UTILITY(U,$J,358.3,25535,0)
 ;;=D84.1^^107^1221^16
 ;;^UTILITY(U,$J,358.3,25535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25535,1,3,0)
 ;;=3^Defects in Complement System
 ;;^UTILITY(U,$J,358.3,25535,1,4,0)
 ;;=4^D84.1
 ;;^UTILITY(U,$J,358.3,25535,2)
 ;;=^5002439
 ;;^UTILITY(U,$J,358.3,25536,0)
 ;;=D81.810^^107^1221^5
 ;;^UTILITY(U,$J,358.3,25536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25536,1,3,0)
 ;;=3^Biotinidase Deficiency
 ;;^UTILITY(U,$J,358.3,25536,1,4,0)
 ;;=4^D81.810
 ;;^UTILITY(U,$J,358.3,25536,2)
 ;;=^5002422
 ;;^UTILITY(U,$J,358.3,25537,0)
 ;;=E88.01^^107^1221^2
 ;;^UTILITY(U,$J,358.3,25537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25537,1,3,0)
 ;;=3^Apha-1 Antitrypsin Deficiency
 ;;^UTILITY(U,$J,358.3,25537,1,4,0)
 ;;=4^E88.01
 ;;^UTILITY(U,$J,358.3,25537,2)
 ;;=^331442
 ;;^UTILITY(U,$J,358.3,25538,0)
 ;;=J09.X1^^107^1221^25
 ;;^UTILITY(U,$J,358.3,25538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25538,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Pneumonia
 ;;^UTILITY(U,$J,358.3,25538,1,4,0)
 ;;=4^J09.X1
 ;;^UTILITY(U,$J,358.3,25538,2)
 ;;=^5008144
 ;;^UTILITY(U,$J,358.3,25539,0)
 ;;=J09.X2^^107^1221^26
 ;;^UTILITY(U,$J,358.3,25539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25539,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Resp Manifest
 ;;^UTILITY(U,$J,358.3,25539,1,4,0)
 ;;=4^J09.X2
 ;;^UTILITY(U,$J,358.3,25539,2)
 ;;=^5008145
 ;;^UTILITY(U,$J,358.3,25540,0)
 ;;=J09.X3^^107^1221^27
 ;;^UTILITY(U,$J,358.3,25540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25540,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ GI Manifest
 ;;^UTILITY(U,$J,358.3,25540,1,4,0)
 ;;=4^J09.X3
 ;;^UTILITY(U,$J,358.3,25540,2)
 ;;=^5008146
 ;;^UTILITY(U,$J,358.3,25541,0)
 ;;=J09.X9^^107^1221^28
 ;;^UTILITY(U,$J,358.3,25541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25541,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Oth Manifest
 ;;^UTILITY(U,$J,358.3,25541,1,4,0)
 ;;=4^J09.X9
 ;;^UTILITY(U,$J,358.3,25541,2)
 ;;=^5008147
 ;;^UTILITY(U,$J,358.3,25542,0)
 ;;=J44.9^^107^1221^14
 ;;^UTILITY(U,$J,358.3,25542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25542,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,25542,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,25542,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,25543,0)
 ;;=J44.1^^107^1221^12
 ;;^UTILITY(U,$J,358.3,25543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25543,1,3,0)
 ;;=3^COPD w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,25543,1,4,0)
 ;;=4^J44.1
 ;;^UTILITY(U,$J,358.3,25543,2)
 ;;=^5008240
 ;;^UTILITY(U,$J,358.3,25544,0)
 ;;=J42.^^107^1221^10
 ;;^UTILITY(U,$J,358.3,25544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25544,1,3,0)
 ;;=3^Bronchitis,Unspec Chronic
 ;;^UTILITY(U,$J,358.3,25544,1,4,0)
 ;;=4^J42.
 ;;^UTILITY(U,$J,358.3,25544,2)
 ;;=^5008234
